Sivik Global Healthcare’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-40,000	Closed	-$1.44M	–	51
2019 Q3	$1.44M	Sell	40,000 -10,000	-20%	-$360K	0.73%	39
2019 Q2	$1.34M	Buy	+50,000	New	+$1.34M	0.32%	59
2018 Q3	–	Sell	-47,351	Closed	-$723K	–	61
2018 Q2	$723K	Buy	+47,351	New	+$723K	0.28%	60
2018 Q1	–	Sell	-65,000	Closed	-$1.96M	–	59
2017 Q4	$1.96M	Sell	65,000 -55,000	-46%	-$1.66M	0.73%	59
2017 Q3	$4.52M	Buy	120,000 +65,000	+118%	+$2.45M	1.54%	26
2017 Q2	$1.53M	Sell	55,000 -10,000	-15%	-$279K	0.56%	61
2017 Q1	$2.24M	Sell	65,000 -5,000	-7%	-$172K	1.04%	37
2016 Q4	$2.02M	Buy	70,000 +4,423	+7%	+$128K	0.96%	39
2016 Q3	$2.09M	Buy	65,577 +8,077	+14%	+$257K	1.05%	37
2016 Q2	$1.87M	Sell	57,500 -42,500	-43%	-$1.38M	0.93%	49
2016 Q1	$2.8M	Buy	100,000 +40,000	+67%	+$1.12M	1.24%	33
2015 Q4	$2.14M	Buy	60,000 +3,686	+7%	+$131K	1.02%	46
2015 Q3	$1.86M	Buy	56,314 +6,314	+13%	+$209K	0.9%	45
2015 Q2	$2.09M	Buy	50,000 +15,000	+43%	+$628K	0.73%	54
2015 Q1	$1.14M	Buy	+35,000	New	+$1.14M	0.39%	72